Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients

Abroad (travel likely)RecruitingPHASE1

Conditions

Epilepsy · Healthy Volunteer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Center for Neurosciences, Tucson, Arizona, United States
Contact: Study coordinator (Crystal Placencia, BS) · ClinicalTrials@neurotucson.com · 520-529-5234
Accel Research sites network, DeLand, Florida, United States
Contact: Study coordinator (Michael Hoffmann, MD) · machael.hoffmann@accelclinical.com · 3867852400
D&H Tamarac Research Center, LLC, Tamarac, Florida, United States
Contact: Study coordinator (Neri Barnea, MD) · drbarnea@nrcinc.com · 786-375-6210
Encore Medical Research of Weston, LLC, Weston, Florida, United States
Contact: Study coordinator (Ninett Llerena, RN) · nllerena@encoremedicalresearch.com · 954-777-8827
Hawaii Pacific Neuroscience, Comprehensive Epilepsy Center, Honolulu, Hawaii, United States
Contact: Study coordinator (Darren Dugas, MD) · info@hawaiineuroscience.com · 800-564-6141
Mid-Atlantic Epilepsy and Sleep Center, Bathesda, Maryland, United States
Contact: Study coordinator (Pavel Klein, MD) · kleinp@epilepsydc.com · 301-530-9744
Quest Research Institute, Farmington Hills, Michigan, United States
Contact: Study coordinator (Aaron Ellenbogen, DO) · aaron@questri.com · 2489578940
Dent Neurologic Institute, Amherst, New York, United States
Contact: Study coordinator (Jacara Washington) · jwashington@dentinstitute.com · 716-961-9220
OnSite Clinical Solutions, LLC, Charlotte, North Carolina, United States
Contact: Study coordinator (Kenneth Ashkin, MD) · kashkinMD@onsiteclinical.com · 800-785-3150
Horizon Clinical Research Center, Cypress, Texas, United States
Contact: Study coordinator (Harpaul Gill, MD) · trials@horizoncrg.com · 281-803-9960

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years

KCNT1-Related Epilepsy

Abroad (travel likely)RecruitingPHASE1

Sydney, Australia

Pharmacological Modulation of Brain Oscillations in Memory Processing

Epilepsy · Seizures · Cognitive Impairment, Mild

Abroad (travel likely)RecruitingEARLY_PHASE1

Dallas, United States

A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures

Epilepsy, Generalized · Epilepsy, Absence

Abroad (travel likely)RecruitingPHASE2

Little Rock, United States

Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 Trials

Refractory Epilepsy in Children · Refractory Epilepsy · Epilepsy

Abroad (travel likely)RecruitingPHASE3

Utrecht, Netherlands